Literature DB >> 26294106

Management of advanced corneal ectasias.

Prafulla K Maharana1, Aditi Dubey1, Vishal Jhanji2, Namrata Sharma3, Sujata Das4, Rasik B Vajpayee5.   

Abstract

Corneal ectasias include a group of disorders characterised by progressive thinning, bulging and distortion of the cornea. Keratoconus is the most common disease in this group. Other manifestations include pellucid marginal degeneration, Terrien's marginal degeneration, keratoglobus and ectasias following surgery. Advanced ectasias usually present with loss of vision due to high irregular astigmatism. Management of these disorders is difficult due to the peripheral location of ectasia and associated severe corneal thinning. Newer contact lenses such as scleral lenses are helpful in a selected group of patients. A majority of these cases requires surgical intervention. This review provides an update on the current treatment modalities available for management of advanced corneal ectasias. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Cornea; Treatment Surgery; Treatment other

Mesh:

Year:  2015        PMID: 26294106     DOI: 10.1136/bjophthalmol-2015-307059

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  11 in total

1.  Risk profiles of ectasia after keratorefractive surgery.

Authors:  Pushpanjali Giri; Dimitri T Azar
Journal:  Curr Opin Ophthalmol       Date:  2017-07       Impact factor: 3.761

Review 2.  Post Penetrating Keratoplasty Ectasia: Incidence, Risk Factors, Clinical Features, and Treatment Options.

Authors:  Antonio Moramarco; Lorenzo Gardini; Danilo Iannetta; Piera Versura; Luigi Fontana
Journal:  J Clin Med       Date:  2022-05-10       Impact factor: 4.964

3.  Candida parapsilosis Infection After Crescentic Lamellar Wedge Resection in Pellucid Marginal Degeneration.

Authors:  Selma Özbek-Uzman; Ayşe Burcu; Züleyha Yalnız-Akkaya; Evin Şingar-Özdemir; Firdevs Örnek
Journal:  Turk J Ophthalmol       Date:  2018-06-28

4.  Characterization of non-linear mechanical behavior of the cornea.

Authors:  A Ashofteh Yazdi; J Melchor; J Torres; I Faris; A Callejas; M Gonzalez-Andrades; G Rus
Journal:  Sci Rep       Date:  2020-07-14       Impact factor: 4.379

5.  Protocol for a systematic review, meta-analysis, and trial sequential analysis of clinical outcomes following accelerated versus conventional corneal collagen cross-linking for corneal ectasia.

Authors:  Siddharth Nath; Carl Shen; Alex Koziarz; Laura Banfield
Journal:  Syst Rev       Date:  2019-04-04

6.  Late detachment of Descemet's membrane after penetrating keratoplasty for pellucid marginal degeneration.

Authors:  Jonathan Lin; Salima Hassanaly; Robert A Hyde; Jennifer Brown; Dan Yoon; Charles Q Yu
Journal:  Am J Ophthalmol Case Rep       Date:  2018-12-18

7.  Transepithelial versus epithelium-off corneal collagen cross-linking for corneal ectasia: protocol for a systematic review, meta-analysis and trial sequential analysis of randomised controlled trials.

Authors:  Siddharth Nath; Carl Shen; Alex Koziarz; Laura Banfield; Mark A Fava; William G Hodge
Journal:  BMJ Open       Date:  2019-05-27       Impact factor: 2.692

8.  Treating refractory corneal hydrops in a male patient with vernal keratoconjunctivitis and mental retardation: a case report.

Authors:  En-Jie Shih; Jung-Chia Lin; Kai-Ling Peng; Jiunn-Liang Chen
Journal:  BMC Ophthalmol       Date:  2022-01-24       Impact factor: 2.209

9.  Commentary: Clinical profile and demographic distribution of Terrien's marginal degeneration in a multitier ophthalmology network in India.

Authors:  Prafulla Kumar Maharana; Ritu Nagpal
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

10.  Tear Mediators in Corneal Ectatic Disorders.

Authors:  Dorottya Pásztor; Bence Lajos Kolozsvári; Adrienne Csutak; András Berta; Ziad Hassan; Bernadett Ujhelyi; Péter Gogolák; Mariann Fodor
Journal:  PLoS One       Date:  2016-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.